| Ytd | -14.00% | |
| 1y | -75.43% |
| Open | 3.49 | Prev Close | 3.56 | Low | 3.40 | High | 3.49 | Mkt Cap | 4.50M |
| Vol | 28.72K | Avg Vol | 1.51M | EPS | -6.83 | P/E | -0.50 | Forward P/E | -2.00 |
| Beta | 0.57 | Short Ratio | 1.96 | Inst. Own | 8.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 3.22 | 200-d Avg | 4.55 | 1yr Est | 14.00 |
Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a clinical-stage biotechnology company developing
Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m